The TIGERS-X payload from Chulabhorn Royal Academy has been successfully launched into orbit, marking Thailand’s latest step into advanced space-based biomedical research. The payload is now en route to the International Space Station, where it will be installed and operated as part of ongoing microgravity experiments.
Once aboard the ISS, the Lab-on-Chip system will begin its investigation into pharmaceutical processes in microgravity, focusing on how reduced gravitational forces influence molecular interactions and drug stability. These insights are crucial for the development of medicines that can be produced or stored during long-duration space missions, including future journeys to the Moon and Mars.
The launch of TIGERS-X represents more than a single experiment—it signals Thailand’s entry into the emerging field of space-enabled biotechnology. As space agencies and private companies increasingly look toward in-orbit manufacturing and research, projects like TIGERS-X demonstrate how smaller nations can strategically position themselves within the global space economy through targeted, high-impact scientific missions.